A Study Examining the Medication Apremilast as Treatment for Chronic Itch

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

September 19, 2019

Conditions
Itch
Interventions
DRUG

Apremilast

Apremilast 30 mg BID daily

Trial Locations (1)

63108

Washington University Division of Dermatology, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Washington University School of Medicine

OTHER